Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
Operating cash flow minus capital expenditures
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-378.28M | -1.5% |
| 2024 | $-372.87M | -24.2% |
| 2023 | $-300.33M | -148.4% |
| 2022 | $-120.88M | +39.1% |
| 2021 | $-198.41M | -280.6% |
| 2020 | $-52.13M | +14.5% |
| 2019 | $-60.95M | - |